FDA Faces Dueling Demands On Antibiotic Clinical Trials
Top pharmaceutical companies in letters released Wednesday implored the U.S. Food and Drug Administration to relax clinical trial standards in order to tackle an emerging public health crisis surrounding declining effectiveness...To view the full article, register now.
Already a subscriber? Click here to view full article